Vintafolide (EC145)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Vintafolide (EC145), covering 2014-12-19 to 2015-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) [Phase 2]